NASDAQ:ADMP
Delisted
Adamis Pharmaceuticals Corporation Stock News
$0.775
+0 (+0%)
At Close: Dec 06, 2023
Best Biotech Penny Stocks In Summer 2021? 7 For Your Watchlist
04:05pm, Thursday, 01'st Jul 2021
Are these the best biotech penny stocks to watch right now? The post Best Biotech Penny Stocks In Summer 2021?
Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock?
09:47am, Friday, 18'th Jun 2021
Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.
Best Penny Stocks to Buy on Robinhood? 3 For Your Morning Watchlist
08:58am, Thursday, 17'th Jun 2021
Are these Robinhood penny stocks the best to watch in 2021? The post Best Penny Stocks to Buy on Robinhood?
New Strong Sell Stocks for June 15th
11:16am, Tuesday, 15'th Jun 2021
CTRN, SI, ADMP, ISBA, and DGICA have been added to the Zacks Rank #5 (Strong Sell) List on June 15, 2021
Adamis Pharmaceuticals: Potential COVID Drug Could Reignite Shares
09:36am, Sunday, 13'th Jun 2021
Adamis Pharmaceuticals is preparing to launch a Phase II/III study with TEMPOL in COVID-19 patients. The NIH recently reported that they found TEMPOL inhibits viral replication. I believe TEMPOL could
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19
07:30am, Friday, 11'th Jun 2021
Activities Proceeding for Phase 2/3 Trial Examining the Effects of Tempol for the Treatment of COVID-19 Activities Proceeding for Phase 2/3 Trial Examining the Effects of Tempol for the Treatment of C
ADMP Stock Price: Over 13% Increase Explanation
09:40am, Wednesday, 09'th Jun 2021
The stock price of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) increased by over 13% this morning. This is why it happened.
Adamis Pharma Stock Jumps After Naloxone Injection Under FDA Review For Opioid Overdose
08:37am, Wednesday, 09'th Jun 2021
The FDA has accepted for review Adamis Pharmaceuticals Corporation's (NASDAQ: ADMP) marketing application seeking approval for Zimhi, a naloxone injection for opioid overdose. The agency's target a
Adamis Provides Update on ZIMHI™
07:30am, Wednesday, 09'th Jun 2021
FDA Deems New Drug Application for ZIMHI Complete and Establishes a Target Action Date of November 12, 2021 FDA Deems New Drug Application for ZIMHI Complete and Establishes a Target Action Date of No
Adamis Pharma Stock Jumps as NIH Sees Promise in Tempol for COVID-19
09:51am, Monday, 07'th Jun 2021
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) has highlighted that the National Institutes of Health (NIH) has identified its experimental drug, Tempol, as a potentially potent antiviral for COV
ADMP Stock Price: Over 10% Increase Pre-Market Explanation
09:03am, Monday, 07'th Jun 2021
The stock price of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) increased by over 10% pre-market. This is why it happened.
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19
07:30am, Monday, 07'th Jun 2021
NIH Researchers Contend “Tempol may be a Promising Oral Antiviral Treatment for COVID-19”
ADMP Stock Price: 61.43% Increase Explanation
07:40am, Friday, 04'th Jun 2021
The stock price of Adamis Pharmaceuticals Corp (NASDAQ: ADMP) increased by 61.43% yesterday. This is why it happened.
Why Adamis Shares Are Ripping Higher Today
03:06pm, Thursday, 03'rd Jun 2021
Shares of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) spiked higher in afternoon trading Thursday following some positive tidings on one of its pipeline assets. What Happened: Study of cell cult
Adamis Pharmaceuticals Provides Business Update
07:30am, Tuesday, 01'st Jun 2021
NDA for ZIMHI™ submitted to the FDA; Phase 2/3 clinical trial preparation initiated for Tempol for treatment of COVID-19 NDA for ZIMHI™ submitted to the FDA; Phase 2/3 clinical trial preparation i
